Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kelly Doran to Streptococcus agalactiae

This is a "connection" page, showing publications Kelly Doran has written about Streptococcus agalactiae.

 
Connection Strength
 
 
 
20.390
 
  1. Cohen S, Doran KS. Murine Model of Candida albicans and Streptococcus agalactiae Vaginal Co-Colonization. J Vis Exp. 2026 08 21; (234).
    View in: PubMed
    Score: 0.845
  2. Joyce LR, Brady A, Kim S, Christensen PM, Palmer KL, Guan Z, Siegnethaler JA, Doran KS. Group B streptococcal membrane vesicles induce proinflammatory responses in neonatal meninges. Infect Immun. 2026 Jul 14; 94(7):e0023126.
    View in: PubMed
    Score: 0.836
  3. Keogh RA, Job AM, Joyce LR, Akbari MS, Nguyen A, Kavanaugh JS, Horswill AR, Doran KS. The diabetic wound microenvironment drives emergence and maintenance of CovRS variants in group B Streptococcus. Infect Immun. 2026 Jul 14; 94(7):e0009926.
    View in: PubMed
    Score: 0.835
  4. Cohen S, Crossen AJ, Jensen O, Neely MN, Le Doare K, Nobbs AH, Ost KS, Doran KS. A fungal pathobiont promotes Streptococcus vaginal persistence and pathogenesis through physical and metabolic interactions. Cell Host Microbe. 2026 Jun 10; 34(6):1118-1134.e7.
    View in: PubMed
    Score: 0.829
  5. Marroquin SM, Cohen S, Neely MN, Doran KS. Akkermansia muciniphila impacts group B Streptococcus vaginal colonization. mBio. 2026 06 10; 17(6):e0286825.
    View in: PubMed
    Score: 0.827
  6. Spencer BL, Nguyen DT, Marroquin SM, Gapin L, O Apos Brien RL, Doran KS. Characterization of the Cellular Immune Response to Group B Streptococcal Vaginal Colonization. J Innate Immun. 2025; 17(1):566-578.
    View in: PubMed
    Score: 0.795
  7. Akbari MS, Joyce LR, Spencer BL, Brady A, McIver KS, Doran KS. Identification of glyoxalase A in group B Streptococcus and its contribution to methylglyoxal tolerance and virulence. Infect Immun. 2025 04 08; 93(4):e0054024.
    View in: PubMed
    Score: 0.763
  8. Joyce LR, Kim S, Spencer BL, Christensen PM, Palmer KL, Guan Z, Siegenthaler JA, Doran KS. Streptococcus agalactiae glycolipids promote virulence by thwarting immune cell clearance. Sci Adv. 2024 05 31; 10(22):eadn7848.
    View in: PubMed
    Score: 0.724
  9. Manzer HS, Brunetti T, Doran KS. Identification of a DNA-cytosine methyltransferase that impacts global transcription to promote group B streptococcal vaginal colonization. mBio. 2023 12 19; 14(6):e0230623.
    View in: PubMed
    Score: 0.696
  10. Spencer BL, Tak U, Mendonça JC, Nagao PE, Niederweis M, Doran KS. A type VII secretion system in Group B Streptococcus mediates cytotoxicity and virulence. PLoS Pathog. 2021 12; 17(12):e1010121.
    View in: PubMed
    Score: 0.610
  11. Burcham LR, Le Breton Y, Radin JN, Spencer BL, Deng L, Hiron A, Ransom MR, Mendonça JDC, Belew AT, El-Sayed NM, McIver KS, Kehl-Fie TE, Doran KS. Identification of Zinc-Dependent Mechanisms Used by Group B Streptococcus To Overcome Calprotectin-Mediated Stress. mBio. 2020 11 10; 11(6).
    View in: PubMed
    Score: 0.566
  12. Burcham LR, Spencer BL, Keeler LR, Runft DL, Patras KA, Neely MN, Doran KS. Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLoS One. 2019; 14(12):e0226699.
    View in: PubMed
    Score: 0.532
  13. Deng L, Spencer BL, Holmes JA, Mu R, Rego S, Weston TA, Hu Y, Sanches GF, Yoon S, Park N, Nagao PE, Jenkinson HF, Thornton JA, Seo KS, Nobbs AH, Doran KS. The Group B Streptococcal surface antigen I/II protein, BspC, interacts with host vimentin to promote adherence to brain endothelium and inflammation during the pathogenesis of meningitis. PLoS Pathog. 2019 06; 15(6):e1007848.
    View in: PubMed
    Score: 0.513
  14. Hancock BM, Doran KS. Importance of strain lineages for Group B streptococcal survival. Virulence. 2017 08 18; 8(6):646-648.
    View in: PubMed
    Score: 0.433
  15. Patras KA, Doran KS. A Murine Model of Group B Streptococcus Vaginal Colonization. J Vis Exp. 2016 11 16; (117).
    View in: PubMed
    Score: 0.430
  16. Mu R, Cutting AS, Del Rosario Y, Villarino N, Stewart L, Weston TA, Patras KA, Doran KS. Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells. PLoS One. 2016; 11(4):e0153891.
    View in: PubMed
    Score: 0.413
  17. Patras KA, Wescombe PA, Rösler B, Hale JD, Tagg JR, Doran KS. Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization. Infect Immun. 2015 Sep; 83(9):3438-44.
    View in: PubMed
    Score: 0.389
  18. Stoner TD, Weston TA, Trejo J, Doran KS. Group B streptococcal infection and activation of human astrocytes. PLoS One. 2015; 10(6):e0128431.
    View in: PubMed
    Score: 0.388
  19. Kim BJ, Hancock BM, Bermudez A, Del Cid N, Reyes E, van Sorge NM, Lauth X, Smurthwaite CA, Hilton BJ, Stotland A, Banerjee A, Buchanan J, Wolkowicz R, Traver D, Doran KS. Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest. 2015 Jun; 125(6):2473-83.
    View in: PubMed
    Score: 0.387
  20. Kim BJ, Hancock BM, Del Cid N, Bermudez A, Traver D, Doran KS. Streptococcus agalactiae infection in zebrafish larvae. Microb Pathog. 2015 Feb; 79:57-60.
    View in: PubMed
    Score: 0.379
  21. Cutting AS, Del Rosario Y, Mu R, Rodriguez A, Till A, Subramani S, Gottlieb RA, Doran KS. The role of autophagy during group B Streptococcus infection of blood-brain barrier endothelium. J Biol Chem. 2014 Dec 26; 289(52):35711-23.
    View in: PubMed
    Score: 0.373
  22. Mu R, Kim BJ, Paco C, Del Rosario Y, Courtney HS, Doran KS. Identification of a group B streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis. Infect Immun. 2014 Jun; 82(6):2276-86.
    View in: PubMed
    Score: 0.357
  23. Wang NY, Patras KA, Seo HS, Cavaco CK, Rösler B, Neely MN, Sullam PM, Doran KS. Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization. J Infect Dis. 2014 Sep 15; 210(6):982-91.
    View in: PubMed
    Score: 0.357
  24. Cavaco CK, Patras KA, Zlamal JE, Thoman ML, Morgan EL, Sanderson SD, Doran KS. A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing. Antimicrob Agents Chemother. 2013 Nov; 57(11):5492-9.
    View in: PubMed
    Score: 0.344
  25. Patras KA, Wang NY, Fletcher EM, Cavaco CK, Jimenez A, Garg M, Fierer J, Sheen TR, Rajagopal L, Doran KS. Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization. Cell Microbiol. 2013 Jul; 15(7):1154-67.
    View in: PubMed
    Score: 0.330
  26. Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS. Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol. 2011 Dec; 193(24):6834-42.
    View in: PubMed
    Score: 0.302
  27. Banerjee A, Kim BJ, Carmona EM, Cutting AS, Gurney MA, Carlos C, Feuer R, Prasadarao NV, Doran KS. Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun. 2011 Sep 06; 2:462.
    View in: PubMed
    Score: 0.300
  28. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis. 2009 May 15; 199(10):1479-87.
    View in: PubMed
    Score: 0.255
  29. Quach D, van Sorge NM, Kristian SA, Bryan JD, Shelver DW, Doran KS. The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. J Bacteriol. 2009 Apr; 191(7):2023-32.
    View in: PubMed
    Score: 0.249
  30. Maisey HC, Hensler M, Nizet V, Doran KS. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol. 2007 Feb; 189(4):1464-7.
    View in: PubMed
    Score: 0.213
  31. Alves J, Crestani C, Marroquin SM, Johnston ABE, Ring N, Bowen C, Reglinski M, Doran KS, Zadoks RN, Lynskey NN. Acquisition of a novel restriction modification system regulates genetic flux and gene expression in the hypervirulent and globally disseminated CC17 lineage of group B Streptococcus. Nucleic Acids Res. 2026 Jul 03; 54(13).
    View in: PubMed
    Score: 0.209
  32. Ling J, Joyce LR, Doran KS, Hryckowian AJ. A murine model of adult gastrointestinal colonization by Group B Streptococcus. Infect Immun. 2026 Mar 10; 94(3):e0052725.
    View in: PubMed
    Score: 0.203
  33. Joyce LR, Akbari MS, Nguyen DT, Spencer BL, Rahkola J, McIver KS, Horswill AR, Doran KS, Keogh RA. Global genome analysis identifies glycolipids and lipoteichoic acid alanylation as contributors to group B streptococcal diabetic wound infection. Cell Rep. 2025 11 25; 44(11):116510.
    View in: PubMed
    Score: 0.200
  34. Doran KS, Engelson EJ, Khosravi A, Maisey HC, Fedtke I, Equils O, Michelsen KS, Arditi M, Peschel A, Nizet V. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest. 2005 Sep; 115(9):2499-507.
    View in: PubMed
    Score: 0.198
  35. Doran KS, Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol. 2004 Oct; 54(1):23-31.
    View in: PubMed
    Score: 0.185
  36. Job AM, Doran KS, Spencer BL. A group B streptococcal type VII-secreted LXG toxin mediates interbacterial competition and colonization of the murine female genital tract. mBio. 2024 10 16; 15(10):e0208824.
    View in: PubMed
    Score: 0.184
  37. Doran KS, Liu GY, Nizet V. Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest. 2003 Sep; 112(5):736-44.
    View in: PubMed
    Score: 0.172
  38. Spencer BL, Job AM, Robertson CM, Hameed ZA, Serchejian C, Wiafe-Kwakye CS, Mendonça JC, Apolonio MA, Nagao PE, Neely MN, Korotkova N, Korotkov KV, Patras KA, Doran KS. Heterogeneity of the group B streptococcal type VII secretion system and influence on colonization of the female genital tract. Mol Microbiol. 2023 08; 120(2):258-275.
    View in: PubMed
    Score: 0.170
  39. Akbari MS, Keogh RA, Radin JN, Sanchez-Rosario Y, Johnson MDL, Horswill AR, Kehl-Fie TE, Burcham LR, Doran KS. The impact of nutritional immunity on Group B streptococcal pathogenesis during wound infection. mBio. 2023 08 31; 14(4):e0030423.
    View in: PubMed
    Score: 0.170
  40. Keogh RA, Doran KS. Group B Streptococcus and diabetes: Finding the sweet spot. PLoS Pathog. 2023 02; 19(2):e1011133.
    View in: PubMed
    Score: 0.166
  41. Manzer HS, Nguyen DT, Park JY, Park N, Seo KS, Thornton JA, Nobbs AH, Doran KS. The Group B Streptococcal Adhesin BspC Interacts with Host Cytokeratin 19 To Promote Colonization of the Female Reproductive Tract. mBio. 2022 10 26; 13(5):e0178122.
    View in: PubMed
    Score: 0.161
  42. Burcham LR, Burcham ZM, Akbari MS, Metcalf JL, Doran KS. Interrelated Effects of Zinc Deficiency and the Microbiome on Group B Streptococcal Vaginal Colonization. mSphere. 2022 08 31; 7(4):e0026422.
    View in: PubMed
    Score: 0.160
  43. Burcham LR, Akbari MS, Alhajjar N, Keogh RA, Radin JN, Kehl-Fie TE, Belew AT, El-Sayed NM, McIver KS, Doran KS. Genomic Analyses Identify Manganese Homeostasis as a Driver of Group B Streptococcal Vaginal Colonization. mBio. 2022 06 28; 13(3):e0098522.
    View in: PubMed
    Score: 0.158
  44. Doran KS, Benoit VM, Gertz RE, Beall B, Nizet V. Late-onset group B streptococcal infection in identical twins: insight to disease pathogenesis. J Perinatol. 2002 Jun; 22(4):326-30.
    View in: PubMed
    Score: 0.158
  45. Burcham LR, Bath JR, Werlang CA, Lyon LM, Liu N, Evans C, Ribbeck K, Doran KS. Role of MUC5B during Group B Streptococcal Vaginal Colonization. mBio. 2022 04 26; 13(2):e0003922.
    View in: PubMed
    Score: 0.156
  46. Manzer HS, Villarreal RI, Doran KS. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis. PLoS Pathog. 2022 03; 18(3):e1010397.
    View in: PubMed
    Score: 0.156
  47. Joyce LR, Manzer HS, da C Mendonça J, Villarreal R, Nagao PE, Doran KS, Palmer KL, Guan Z. Identification of a novel cationic glycolipid in Streptococcus agalactiae that contributes to brain entry and meningitis. PLoS Biol. 2022 02; 20(2):e3001555.
    View in: PubMed
    Score: 0.155
  48. Lyon LM, Doran KS. Human Milk Oligosaccharides versus Streptococcus: How a Human-Made Natural Product Protects Us from Pathogens. mSphere. 2022 02 23; 7(1):e0004922.
    View in: PubMed
    Score: 0.155
  49. Doran KS, Chang JC, Benoit VM, Eckmann L, Nizet V. Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis. 2002 Jan 15; 185(2):196-203.
    View in: PubMed
    Score: 0.153
  50. Keogh RA, Spencer BL, Sorensen HM, Zapf RL, Briaud P, Bonsall AE, Doran KS, Carroll RK. Global Annotation, Expression Analysis, and Stability of Candidate sRNAs in Group B Streptococcus. mBio. 2021 12 21; 12(6):e0280321.
    View in: PubMed
    Score: 0.152
  51. de Figueiredo Sanches G, Lannes-Costa PS, Cristoforêto MC, Doran KS, Mattos-Guaraldi AL, Nagao PE. Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro, Brazil. Braz J Microbiol. 2021 Mar; 52(1):303-310.
    View in: PubMed
    Score: 0.143
  52. Lannes-Costa PS, Baraúna RA, Ramos JN, Veras JFC, Conceição MVR, Vieira VV, de Mattos-Guaraldi AL, Ramos RTJ, Doran KS, Silva A, Nagao PE. Comparative genomic analysis and identification of pathogenicity islands of hypervirulent ST-17 Streptococcus agalactiae Brazilian strain. Infect Genet Evol. 2020 06; 80:104195.
    View in: PubMed
    Score: 0.134
  53. Vornhagen J, Armistead B, Santana-Ufret V, Gendrin C, Merillat S, Coleman M, Quach P, Boldenow E, Alishetti V, Leonhard-Melief C, Ngo LY, Whidbey C, Doran KS, Curtis C, Waldorf KMA, Nance E, Rajagopal L. Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection. J Clin Invest. 2018 05 01; 128(5):1985-1999.
    View in: PubMed
    Score: 0.118
  54. Lazzarin M, Mu R, Fabbrini M, Ghezzo C, Rinaudo CD, Doran KS, Margarit I. Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain. BMC Microbiol. 2017 07 03; 17(1):148.
    View in: PubMed
    Score: 0.112
  55. Lin AE, Autran CA, Szyszka A, Escajadillo T, Huang M, Godula K, Prudden AR, Boons GJ, Lewis AL, Doran KS, Nizet V, Bode L. Human milk oligosaccharides inhibit growth of group B Streptococcus. J Biol Chem. 2017 07 07; 292(27):11243-11249.
    View in: PubMed
    Score: 0.111
  56. Patras KA, Rösler B, Thoman ML, Doran KS. Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus. Mucosal Immunol. 2015 Nov; 8(6):1339-48.
    View in: PubMed
    Score: 0.096
  57. Gendrin C, Lembo A, Whidbey C, Burnside K, Berry J, Ngo L, Banerjee A, Xue L, Arrington J, Doran KS, Tao WA, Rajagopal L. The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA. Infect Immun. 2015 Mar; 83(3):1078-88.
    View in: PubMed
    Score: 0.094
  58. Faralla C, Metruccio MM, De Chiara M, Mu R, Patras KA, Muzzi A, Grandi G, Margarit I, Doran KS, Janulczyk R. Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness. mBio. 2014 May 20; 5(3):e00870-14.
    View in: PubMed
    Score: 0.090
  59. Seo HS, Minasov G, Seepersaud R, Doran KS, Dubrovska I, Shuvalova L, Anderson WF, Iverson TM, Sullam PM. Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae. J Biol Chem. 2013 Dec 13; 288(50):35982-96.
    View in: PubMed
    Score: 0.087
  60. Krishnan V, Dwivedi P, Kim BJ, Samal A, Macon K, Ma X, Mishra A, Doran KS, Ton-That H, Narayana SV. Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions. Acta Crystallogr D Biol Crystallogr. 2013 Jun; 69(Pt 6):1073-89.
    View in: PubMed
    Score: 0.084
  61. Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM. Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog. 2012; 8(10):e1002947.
    View in: PubMed
    Score: 0.081
  62. Alkuwaity K, Taylor A, Heckels JE, Doran KS, Christodoulides M. Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro. PLoS One. 2012; 7(8):e42660.
    View in: PubMed
    Score: 0.080
  63. Burnside K, Lembo A, Harrell MI, Gurney M, Xue L, BinhTran NT, Connelly JE, Jewell KA, Schmidt BZ, de Los Reyes M, Tao WA, Doran KS, Rajagopal L. Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus. J Biol Chem. 2011 Dec 23; 286(51):44197-44210.
    View in: PubMed
    Score: 0.076
  64. Lembo A, Gurney MA, Burnside K, Banerjee A, de los Reyes M, Connelly JE, Lin WJ, Jewell KA, Vo A, Renken CW, Doran KS, Rajagopal L. Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. Mol Microbiol. 2010 Jul; 77(2):431-43.
    View in: PubMed
    Score: 0.068
  65. Kaplan A, Chung K, Kocak H, Bertolotto C, Uh A, Hobel CJ, Simmons CF, Doran K, Liu GY, Equils O. Group B streptococcus induces trophoblast death. Microb Pathog. 2008 Sep; 45(3):231-5.
    View in: PubMed
    Score: 0.060
  66. Hensler ME, Quach D, Hsieh CJ, Doran KS, Nizet V. CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microb Pathog. 2008 Jan; 44(1):84-8.
    View in: PubMed
    Score: 0.057
  67. Kim S, Joyce LR, Brady A, Spencer BL, Pawlikowski B, Derk J, Doran KS, Siegenthaler JA. Meningeal inflammation and arachnoid barrier breakdown in a mouse model of neonatal bacterial meningitis. Cell Rep. 2026 Oct 27; 45(10):118141.
    View in: PubMed
    Score: 0.053
  68. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, Tissi L, Nizet V. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A. 2004 Oct 05; 101(40):14491-6.
    View in: PubMed
    Score: 0.046
  69. Pinho-Ribeiro FA, Deng L, Neel DV, Erdogan O, Basu H, Yang D, Choi S, Walker AJ, Carneiro-Nascimento S, He K, Wu G, Stevens B, Doran KS, Levy D, Chiu IM. Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion. Nature. 2023 03; 615(7952):472-481.
    View in: PubMed
    Score: 0.042
  70. van Sorge NM, Bonsor DA, Deng L, Lindahl E, Schmitt V, Lyndin M, Schmidt A, Nilsson OR, Brizuela J, Boero E, Sundberg EJ, van Strijp JAG, Doran KS, Singer BB, Lindahl G, McCarthy AJ. Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. EMBO J. 2021 04 01; 40(7):e106103.
    View in: PubMed
    Score: 0.036
  71. Kim BJ, McDonagh MA, Deng L, Gastfriend BD, Schubert-Unkmeir A, Doran KS, Shusta EV. Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells. Fluids Barriers CNS. 2019 Aug 22; 16(1):26.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)